https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-08-01 / Clin. Exp. Pharmacol. Physiol. 2012 Aug;39(8):725-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-08-01 / Clin. Exp. Pharmacol. Physiol. 2012 Aug;39(8):725-302012-08-01 00:00:002019-02-15 09:21:33Newcastle disease virus: a promising agent for tumour immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-07-18 / Viral Immunol. 2012 Aug;25(4):268-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-07-18 / Viral Immunol. 2012 Aug;25(4):268-762012-07-18 00:00:002019-02-15 09:21:29Cell-type-specific innate immune response to oncolytic Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1817-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1817-332012-07-01 00:00:002019-02-15 09:23:09Bugs and drugs: oncolytic virotherapy in combination with chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1834-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1834-412012-07-01 00:00:002019-02-15 09:21:39Recent clinical experience with oncolytic viruses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-05-29 / Appl. Biochem. Biotechnol. 2012 Aug;167(7):2005-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-05-29 / Appl. Biochem. Biotechnol. 2012 Aug;167(7):2005-222012-05-29 00:00:002019-02-15 09:21:30Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-04-18 / Hum. Gene Ther. 2012 Jul;23(7):700-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-04-18 / Hum. Gene Ther. 2012 Jul;23(7):700-102012-04-18 00:00:002019-02-15 09:21:30Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-08 / Arch. Virol. 2012 Jun;157(6):1011-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-08 / Arch. Virol. 2012 Jun;157(6):1011-82012-03-08 00:00:002012-03-08 00:00:00Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-03-01 / Future Microbiol 2012 Mar;7(3):347-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-03-01 / Future Microbiol 2012 Mar;7(3):347-672012-03-01 00:00:002019-02-15 09:21:32Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-02-29 / Neuroendocrinology 2013;97(1):26-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-02-29 / Neuroendocrinology 2013;97(1):26-342012-02-29 00:00:002019-02-15 09:22:48Virotherapy of neuroendocrine tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-02-15 / Pediatr. Res. 2012 Apr;71(4 Pt 2):500-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-02-15 / Pediatr. Res. 2012 Apr;71(4 Pt 2):500-102012-02-15 00:00:002019-02-15 09:21:31Targeting pediatric cancer stem cells with oncolytic virotherapy
